FARAH CHAMPSI Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for FARAH CHAMPSI.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of FARAH CHAMPSI. FARAH CHAMPSI is Director in Kite Pharma, Inc. ($KITE) and Director in Population Health Investment Co., Inc. ($PHIC).
Latest Insider Trading Transactions of FARAH CHAMPSI
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 26 2021 | PHIC | Population Health ... | CHAMPSI FARAH | Director | Option Exercise | J | 0.00 | 43,125 | 0 | 43,125 | |
| Oct 05 2017 | KITE | Kite Pharma, Inc. | CHAMPSI FARAH | Director | Option Exercise | D | 91.21 | 8,810 | 803,560 | 0 | |
| Oct 05 2017 | KITE | Kite Pharma, Inc. | CHAMPSI FARAH | Director | Option Exercise | D | 50.87 | 7,000 | 356,090 | 0 | |
| Oct 05 2017 | KITE | Kite Pharma, Inc. | CHAMPSI FARAH | Director | Option Exercise | D | 59.23 | 10,000 | 592,300 | 0 | |
| Oct 05 2017 | KITE | Kite Pharma, Inc. | CHAMPSI FARAH | Director | Option Exercise | D | 1.35 | 50,000 | 67,500 | 0 | |
| Oct 05 2017 | KITE | Kite Pharma, Inc. | CHAMPSI FARAH | Director | Sell | D | 0.00 | 1,807 | 0 | 0 | 1.8 K to 0 (-100.00 %) |
| Oct 05 2017 | KITE | Kite Pharma, Inc. | CHAMPSI FARAH | Director | Sell | U | 180.00 | 61,467 | 11,064,060 | 1,807 | 63.3 K to 1.8 K (-97.14 %) |
| Oct 05 2017 | KITE | Kite Pharma, Inc. | CHAMPSI FARAH | Director | Gift | G | 0.00 | 2,800 | 0 | 63,274 | 66.1 K to 63.3 K (-4.24 %) |
| Jun 22 2017 | KITE | Kite Pharma, Inc. | CHAMPSI FARAH | Director | Option Exercise | A | 91.21 | 8,810 | 803,560 | 8,810 | |
| Jun 22 2017 | KITE | Kite Pharma, Inc. | CHAMPSI FARAH | Director | Grant | A | 0.00 | 2,410 | 0 | 66,074 | 63.7 K to 66.1 K (+3.79 %) |
| Jun 16 2017 | KITE | Kite Pharma, Inc. | CHAMPSI FARAH | Director | Sell | S | 88.11 | 5,450 | 480,200 | 0 | 5.5 K to 0 (-100.00 %) |
| Jun 16 2017 | KITE | Kite Pharma, Inc. | CHAMPSI FARAH | Director | Sell | S | 90.40 | 15,000 | 1,356,000 | 63,664 | 78.7 K to 63.7 K (-19.07 %) |
| May 01 2017 | KITE | Kite Pharma, Inc. | CHAMPSI FARAH | Director | Sell | S | 82.59 | 2,617 | 216,138 | 4,962 | 7.6 K to 5 K (-34.53 %) |
| May 01 2017 | KITE | Kite Pharma, Inc. | CHAMPSI FARAH | Director | Sell | S | 82.77 | 16,551 | 1,369,926 | 7,579 | 24.1 K to 7.6 K (-68.59 %) |
| Apr 26 2017 | KITE | Kite Pharma, Inc. | CHAMPSI FARAH | Director | Sell | S | 83.06 | 200 | 16,612 | 24,130 | 24.3 K to 24.1 K (-0.82 %) |
| Apr 26 2017 | KITE | Kite Pharma, Inc. | CHAMPSI FARAH | Director | Sell | S | 82.72 | 51,112 | 4,227,985 | 24,330 | 75.4 K to 24.3 K (-67.75 %) |
| Apr 26 2017 | KITE | Kite Pharma, Inc. | CHAMPSI FARAH | Director | Sell | S | 83.29 | 15,316 | 1,275,670 | 75,442 | 90.8 K to 75.4 K (-16.88 %) |
| Apr 26 2017 | KITE | Kite Pharma, Inc. | CHAMPSI FARAH | Director | Sell | S | 82.56 | 31,467 | 2,597,916 | 90,758 | 122.2 K to 90.8 K (-25.75 %) |
| Apr 26 2017 | KITE | Kite Pharma, Inc. | CHAMPSI FARAH | Director | Sell | S | 82.34 | 25,818 | 2,125,854 | 122,225 | 148 K to 122.2 K (-17.44 %) |
| Apr 17 2017 | KITE | Kite Pharma, Inc. | CHAMPSI FARAH | Director | Sell | S | 83.06 | 100 | 8,306 | 148,043 | 148.1 K to 148 K (-0.07 %) |
| Apr 17 2017 | KITE | Kite Pharma, Inc. | CHAMPSI FARAH | Director | Sell | S | 82.48 | 43,001 | 3,546,722 | 148,143 | 191.1 K to 148.1 K (-22.50 %) |
| Apr 17 2017 | KITE | Kite Pharma, Inc. | CHAMPSI FARAH | Director | Sell | S | 82.39 | 72,275 | 5,954,737 | 191,144 | 263.4 K to 191.1 K (-27.44 %) |
| Jun 03 2016 | KITE | Kite Pharma, Inc. | CHAMPSI FARAH | Director | Option Exercise | A | 50.87 | 7,000 | 356,090 | 7,000 | |
| Jun 03 2016 | KITE | Kite Pharma, Inc. | CHAMPSI FARAH | Director | Grant | A | 0.00 | 1,950 | 0 | 21,616 | 19.7 K to 21.6 K (+9.92 %) |
| Jul 02 2015 | KITE | Kite Pharma, Inc. | CHAMPSI FARAH | Director | Sell | S | 63.82 | 500 | 31,910 | 1,761,957 | 1.8 M to 1.8 M (-0.03 %) |
| Jul 02 2015 | KITE | Kite Pharma, Inc. | CHAMPSI FARAH | Director | Sell | S | 63.01 | 358,757 | 22,605,279 | 1,762,457 | 2.1 M to 1.8 M (-16.91 %) |
| Jul 02 2015 | KITE | Kite Pharma, Inc. | CHAMPSI FARAH | Director | Sell | S | 62.14 | 113,047 | 7,024,741 | 2,121,214 | 2.2 M to 2.1 M (-5.06 %) |
| Jul 02 2015 | KITE | Kite Pharma, Inc. | CHAMPSI FARAH | Director | Sell | S | 61.22 | 191,798 | 11,741,874 | 2,234,261 | 2.4 M to 2.2 M (-7.91 %) |
| Jun 17 2015 | KITE | Kite Pharma, Inc. | CHAMPSI FARAH | Director | Option Exercise | A | 59.23 | 10,000 | 592,300 | 10,000 |
Page: 1